Jacobio Pharmaceuticals insider group boosts shareholding

From September 1 to September 3, 2025, parties acting in concert with Jacobio Pharmaceuticals Group Co. acquired an additional 402,000 shares on the open market. These purchases were made at an average price of HK$10.16 per share. Following these transactions, the concert parties now collectively hold 201,157,285 shares, representing approximately 25.41% of the total issued shares of the company.

The concert parties expressed strong confidence in the company's overall development prospects, growth potential, and the long-term investment value of its shares. They also indicated that they do not rule out the possibility of further increasing their shareholdings, subject to compliance with applicable laws and regulatory requirements.

The shareholding increase was conducted in accordance with applicable laws, rules, and regulations, including the Model Code for Securities Transactions by Directors of Listed Issuers. The board of directors, as of September 4, 2025, includes Dr. Yinxiang Wang as chairman and executive director, Ms. Xiaojie Wang and Ms. Yunyan Hu as executive directors, Dr. Te-li Chen as non-executive director, and Dr. Ruilin Song, Dr. Bai Lu and Dr. Ge Wu as independent non-executive directors.